News

Fact checked by Jennifer Klump Key Takeaways The FDA approved the obesity drug Wegovy as a treatment for people with MASH ...
As appetite-suppressing drugs change the way people eat, businesses are adapting to GLP-1 users by offering smaller portions ...
A growing number of patients claim popular weight loss and diabetes drugs like Ozempic can cause a rare but very serious side ...
Williams is not the first sportsperson to promote GLP-1 weight loss medication but she is the most high profile and easily ...
Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a new dilemma: What happens if they stop taking them? Many worry that they’ll ...
Like semaglutide, the new drug known as ecnoglutide is glucagon-like peptide-1 receptor agonist. In simple terms, they both ...
As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The ...
Recently, tennis legend Serena Williams opened up about using weight-loss medication, aiming to break the ‘stigma’ around ...
My name is Louise, and I am addicted to Mounjaro. I feel amazing - super healthy, energised, and happier in my skin than I ...
Eli Lilly and Company (NYSE: LLY) is one of the best stocks to invest in for long-term growth. Eli Lilly and Company ...
Given the potential side effects of GLP-1 prescription drugs, many Utahns are seeking alternative methods to naturally boost ...